» Articles » PMID: 12522099

ADP Stimulation of Inositol Phosphates in Hepatocytes: Role of Conversion to ATP and Stimulation of P2Y2 Receptors

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2003 Jan 11
PMID 12522099
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

1 Accumulation of inositol (poly)phosphates (InsP(x)) has been studied in rat hepatocytes labelled with [(3)H]inositol. Stimulation with ADP resulted in a significant increase in total [(3)H]InsP(x), whereas 2-MeSADP had only a small effect and ADPbetaS was ineffective. UTP and ITP also stimulated substantial increases in [(3)H]InsP(x). 2 The dose-response curve to ADP was largely unaltered by the presence of the P2Y(1) antagonist, adenosine-3'-phosphate-5'-phosphate (A3P5P). Similarly, inclusion of MRS 2179, a more selective P2Y(1) antagonist, had no effect on the dose-response curve to ADP. 3 The inclusion of hexokinase in the assay reduced, but did not abolish, the response to ADP. 4 HPLC analysis revealed that ADP in the medium was rapidly converted to AMP and ATP. The inclusion of hexokinase removed ATP, but exacerbated the decline in ADP concentration, leading to increased levels of AMP. 2-MeSADP was stable in the medium and ATP was largely unaffected. 5 The addition of the adenylate kinase inhibitor, diadenosine pentaphosphate (Ap(5)A) significantly reduced the ADP response. HPLC analysis conducted in parallel demonstrated that this treatment inhibited conversion of ADP to ATP and AMP. 6 Inclusion of the P1 antagonist CGS 15943 had no effect on the dose-response curve to ADP. 7 These observations indicate that hepatocytes respond to ADP with an increase in inositol (poly)phosphates following conversion to ATP. P2Y(1) activation in hepatocytes does not appear to be coupled to inositol 1,4,5-trisphosphate (Ins(1,4,5)P(3)) production.

Citing Articles

Receptor-specific Ca oscillation patterns mediated by differential regulation of P2Y purinergic receptors in rat hepatocytes.

Correa-Velloso J, Bartlett P, Brumer R, Gaspers L, Ulrich H, Thomas A iScience. 2021; 24(10):103139.

PMID: 34646983 PMC: 8496176. DOI: 10.1016/j.isci.2021.103139.


Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.

Chatterjee C, Sparks D PLoS One. 2012; 7(5):e36916.

PMID: 22590634 PMC: 3349634. DOI: 10.1371/journal.pone.0036916.


The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X Front Biosci. 2007; 13:2588-603.

PMID: 17981736 PMC: 2892180. DOI: 10.2741/2868.

References
1.
Dixon C, Woods N, Webb T, Green A . Evidence that rat hepatocytes co-express functional P2Y1 and P2Y2 receptors. Br J Pharmacol. 2000; 129(4):764-70. PMC: 1571892. DOI: 10.1038/sj.bjp.0703103. View

2.
Webb T, Henderson D, Roberts J, Barnard E . Molecular cloning and characterization of the rat P2Y4 receptor. J Neurochem. 1998; 71(4):1348-57. DOI: 10.1046/j.1471-4159.1998.71041348.x. View

3.
Yegutkin G, Henttinen T, Jalkanen S . Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J. 2001; 15(1):251-260. DOI: 10.1096/fj.00-0268com. View

4.
Zambon A, Brunton L, Barrett K, Hughes R, Torres B, Insel P . Cloning, expression, signaling mechanisms, and membrane targeting of P2Y(11) receptors in Madin Darby canine kidney cells. Mol Pharmacol. 2001; 60(1):26-35. DOI: 10.1124/mol.60.1.26. View

5.
Qi A, Zambon A, Insel P, Nicholas R . An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors. Mol Pharmacol. 2001; 60(6):1375-82. DOI: 10.1124/mol.60.6.1375. View